14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.18 $4.49 Friday, 17th May 2024 ELEV stock ended at $3.61. During the day the stock fluctuated 4.86% from a day low at $3.50 to a day high of $3.67.
90 days $2.54 $5.83
52 weeks $0.363 $5.89

Historical Elevation Oncology, Inc. prices

Date Open High Low Close Volume
Apr 12, 2024 $4.92 $4.92 $4.50 $4.73 617 382
Apr 11, 2024 $4.65 $4.98 $4.61 $4.94 374 421
Apr 10, 2024 $4.59 $4.67 $4.51 $4.60 249 972
Apr 09, 2024 $4.68 $4.75 $4.54 $4.71 449 170
Apr 08, 2024 $4.86 $4.86 $4.40 $4.64 774 893
Apr 05, 2024 $5.14 $5.14 $4.59 $4.91 1 079 074
Apr 04, 2024 $5.25 $5.59 $4.81 $5.06 1 202 261
Apr 03, 2024 $5.00 $5.83 $4.98 $5.17 2 043 984
Apr 02, 2024 $4.99 $5.21 $4.90 $5.13 3 448 146
Apr 01, 2024 $5.19 $5.21 $4.78 $4.99 399 333
Mar 28, 2024 $5.04 $5.26 $4.92 $5.13 438 259
Mar 27, 2024 $5.14 $5.39 $4.90 $5.01 1 282 347
Mar 26, 2024 $4.59 $5.03 $4.56 $5.00 1 026 216
Mar 25, 2024 $4.50 $4.81 $4.42 $4.58 693 601
Mar 22, 2024 $4.61 $4.83 $4.40 $4.50 464 915
Mar 21, 2024 $4.41 $4.77 $4.39 $4.51 453 472
Mar 20, 2024 $4.34 $4.43 $4.20 $4.34 453 550
Mar 19, 2024 $4.37 $4.59 $4.28 $4.40 473 178
Mar 18, 2024 $4.41 $4.45 $4.15 $4.36 759 309
Mar 15, 2024 $3.97 $4.51 $3.97 $4.39 731 002
Mar 14, 2024 $4.21 $4.39 $3.92 $3.96 431 396
Mar 13, 2024 $4.08 $4.26 $4.04 $4.17 328 712
Mar 12, 2024 $4.34 $4.41 $3.97 $4.08 1 209 118
Mar 11, 2024 $4.70 $4.70 $4.35 $4.39 591 630
Mar 08, 2024 $4.52 $4.80 $4.39 $4.57 985 922

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use ELEV stock historical prices to predict future price movements?
Trend Analysis: Examine the ELEV stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the ELEV stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About Elevation Oncology, Inc.

Elevation Oncology. Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is bas... ELEV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT